Eni, the Italian energy group, signed a memorandum of understanding with Genoa humanoid maker Generative Bionics on September 30, 2026 in San Donato Milanese. The two will assess using Generative Bionics’ GENE.01 robot at Eni industrial and operational sites, sourcing materials for it from Eni’s chemicals arm Versalis, and possibly giving the start-up access to Eni’s high-performance computing. The agreement is exploratory: no order, volume or value has been disclosed.

Why it matters: Eni’s venture arm Eni Next invested in Generative Bionics in December 2025. With this MoU, one company is lined up as investor, supplier and test customer for the same humanoid.

Key Facts

  • MoU signed September 30, 2026 in San Donato Milanese; exploratory, no financial terms disclosed (Eni)
  • Target uses at Eni sites: inspection, teleoperation, remote assistance and support in complex environments
  • Versalis and its company Finproject may help build a lighter, stronger foot and footwear system for GENE.01
  • Eni Next took part in Generative Bionics’ €70 million round, announced December 9, 2025 and led by CDP Venture Capital’s AI fund

What does the agreement cover?

Six strands, all worded in Eni’s release as areas to “assess” or “identify”. The first is use cases at Eni plants: inspection, teleoperation, remote assistance and support in complex environments, with safety and efficiency named as the goals. The second is components and materials drawn from the Versalis portfolio. The third is GENE.01’s foot and footwear system. The fourth is the industrialisation and commercialisation of Generative Bionics’ sensorised footwear using Eni’s materials, expertise and market channels. The fifth is whether Eni sites could host future production, assembly and testing of the robots, possibly including battery use, disposal and recycling. The sixth is access to Eni’s HPC to develop, train and validate physical-AI models.

Generative Bionics is a spin-off of the Italian Institute of Technology (IIT) led by chief executive Daniele Pucci, with about 110 staff, according to Il Sole 24 Ore on October 1. It unveiled GENE.01, which carries a full-body tactile skin, in July 2026. Its first industrial configuration is a welder for the shipbuilder Fincantieri under a four-year programme; Il Sole 24 Ore reports a first deployment scheduled for early 2027, with pre-orders expected to open in the second quarter of 2027.

Why would an oil major work on a robot’s feet?

Because that is where its chemicals business fits. Eni’s release sets specific targets for the foot: lighter, stronger and more scalable, with better impact absorption, grip, durability and ease of assembly. Finproject, which the release describes as a Versalis company making ultra-lightweight products, may contribute. A walking robot’s feet take an impact on every step, which is why durability sits on that list. If robot footwear wears out the way shoes do, it becomes a recurring purchase and a steady market for materials, in a way a robot’s torso is not.

The footwear strand also goes beyond the robot. The MoU covers commercialising Generative Bionics’ sensorised footwear through Eni’s channels, which implies a product that could be sold on its own. Neither company has said to whom, or when.

The test-site strand is the more familiar pattern. Industrial owners with hazardous sites are becoming the first proving grounds for humanoids, as with Fincantieri here and Persona AI’s welding work aimed at HD Hyundai’s yards. What sets the Eni agreement apart is how much of the supply chain one partner could cover: capital, materials, a production location, batteries, compute and the first jobs. Each of those is still conditional on the assessments the MoU sets up.

Frequently Asked

What did Eni and Generative Bionics agree?

A memorandum of understanding, signed on September 30, 2026, to assess collaboration around the GENE.01 humanoid: tests at Eni sites, materials from Versalis, a new foot and footwear system, batteries and possible access to Eni’s high-performance computing. No financial terms were disclosed.

Is Eni an investor in Generative Bionics?

Yes. Eni’s venture arm Eni Next took part in Generative Bionics’ €70 million round, announced in December 2025 and led by CDP Venture Capital.

What is GENE.01?

Generative Bionics’ humanoid robot, unveiled in July 2026, with a full-body tactile skin. Its first industrial configuration is a welding robot for the shipbuilder Fincantieri.